Immunic Inc. (IMUX) Reports FY21 EPS of ($3.93)
Tweet
Share
E-mailGet Alerts IMUX Hot Sheet
Join SI Premium – FREE
Immunic Inc. (NASDAQ: IMUX) reported FY21 EPS of ($3.93). Revenue for the quarter came in at $0 , versus $0 reported last year.
For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Core & Main, Inc (CNM) Tops Q3 EPS by 2c ; Offers Guidance
- GameStop (GME) Tops Q2 EPS by 8c
- Chewy (CHWY) Reports In-Line Q2 EPS, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
